2,787
Views
7
CrossRef citations to date
0
Altmetric
Reviews

Cell-free therapy for canine osteoarthritis: current evidence and prospects

ORCID Icon, ORCID Icon, , , , ORCID Icon, ORCID Icon, & show all
Pages 224-230 | Received 23 Jun 2022, Accepted 06 Nov 2022, Published online: 17 Nov 2022

References

  • American College of Veterinary Surgeons. 2022. Osteoarthritis in dogs. (accessed 2022 June 15]. https://www.acvs.org/small-animal/osteoarthritis-in-dogs
  • Anderson KL, Zulch H, O'Neill DG, Meeson RL, Collins LM. 2020. Risk factors for canine osteoarthritis and its predisposing arthropathies: a systematic review. Front Vet Sci. 7:220. PMID: 32411739; PMCID: PMC7198754.
  • Bogers SH. 2018. Cell-based therapies for joint disease in veterinary medicine: what we have learned and what we need to know. Front Vet Sci. 5:70. PMID: 29713634; PMCID: PMC5911772.
  • Brondeel C, Pauwelyn G, de Bakker E, Saunders J, Samoy Y, Spaas JH. 2021. Review: mesenchymal stem cell therapy in canine osteoarthritis research: "experientia docet" (experience will teach us). Front Vet Sci. 8:668881. PMID: 34095280; PMCID: PMC8169969.
  • Chandra V, Sharma GT. 2021. Prospects of mesenchymal stem cell secretome in veterinary regenerative therapy. In: Choudhary RK, Choudhary S, editors. Stem cells in veterinary science. Singapore: Springer; p. 271–287.
  • Cosenza S, Ruiz M, Toupet K, Jorgensen C, Noël D. 2017. Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis. Sci Rep. 7(1):16214. PMID: 29176667; PMCID: PMC5701135.
  • da Costa VR, Araldi RP, Vigerelli H, D’Ámelio F, Mendes TB, Gonzaga V, Policíquio B, Colozza-Gama GA, Valverde CW, Kerkis I. 2021. Exosomes in the tumor microenvironment: from biology to clinical applications. Cells. 10(10):2617. PMID: 34685596; PMCID: PMC8533895.
  • Desando G, Cavallo C, Sartoni F, Martini L, Parrilli A, Veronesi F, Fini M, Giardino R, Facchini A, Grigolo B. 2013. Intra-articular delivery of adipose derived stromal cells attenuates osteoarthritis progression in an experimental rabbit model. Arthritis Res Ther. 15(1):R22. PMID: 23360790; PMCID: PMC3672720.
  • Domaniža M, Trbolová A, Hluchý M, Cížková D. 2021. Mesenchymal stem cell-based treatment of osteoarthritis in dogs – a review. SRDTJ Stem Cell Res Dev Ther. 7(4):1–7.
  • Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, Laine GA, Cox CS. Jr. 2009. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 18(5):683–692. PMID: 19099374; PMCID: PMC3190292.
  • Gugjoo MB, Fazili MR, Gayas MA, Ahmad RA, Dhama K. 2019. Animal mesenchymal stem cell research in cartilage regenerative medicine – a review. Vet Q. 39(1):95–120. PMID: 31291836; PMCID: PMC8923021.
  • Huňáková K, Hluchý M, Špaková T, Matejová J, Mudroňová D, Kuricová M, Rosocha J, Ledecký V. 2020. Study of bilateral elbow joint osteoarthritis treatment using conditioned medium from allogeneic adipose tissue-derived MSCs in Labrador retrievers. Res Vet Sci. 132:513–520. Epub 2020 Aug 8. PMID: 32805699.
  • Hunziker EB, Kapfinger E. 1998. Removal of proteoglycans from the surface of defects in articular cartilage transiently enhances coverage by repair cells. J Bone Joint Surg Br. 80(1):144–150. Jan PMID: 9460972.
  • Ivanovska A, Wang M, Arshaghi TE, Shaw G, Alves J, Byrne A, Butterworth S, Chandler R, Cuddy L, Dunne J, et al. 2022. Manufacturing mesenchymal stromal cells for the treatment of osteoarthritis in canine patients: challenges and recommendations. Front Vet Sci. 9:897150.
  • Jeyaraman M, Muthu S, Gulati A, Jeyaraman N, G S P, Jain R. 2021. Mesenchymal stem cell-derived exosomes: a potential therapeutic avenue in knee osteoarthritis. Cartilage. 13(1_suppl):1572S–1585S. Epub 2020 Oct 5. PMID: 33016114; PMCID: PMC8808857.
  • Johnson KA. 2019. Mesenchymal stem cell treatment of osteoarthritis. Vet Comp Orthop Traumatol. 32(3):v. Epub 2019 May 17. PMID: 31100764.
  • Joseph A, Baiju I, Bhat IA, Pandey S, Bharti M, Verma M, Pratap Singh A, Ansari MM, Chandra V, Saikumar G, et al. 2020. Mesenchymal stem cell-conditioned media: a novel alternative of stem cell therapy for quality wound healing. J Cell Physiol. 235(7–8):5555–5569. Epub 2020 Jan 21. PMID: 31960454.
  • Kang MH, Park HM. 2014. Evaluation of adverse reactions in dogs following intravenous mesenchymal stem cell transplantation. Acta Vet Scand. 56(1):16. PMID: 24655411; PMCID: PMC3994522.
  • Khatab S, van Osch GJ, Kops N, Bastiaansen-Jenniskens YM, Bos PK, Verhaar JA, Bernsen MR, van Buul GM. 2018. Mesenchymal stem cell secretome reduces pain and prevents cartilage damage in a murine osteoarthritis model. Eur Cell Mater. 36:218–230. PMID: 30398288.
  • Kiefer KM, O'Brien TD, Pluhar EG, Conzemius M. 2015. Canine adipose-derived stromal cell viability following exposure to synovial fluid from osteoarthritic joints. Vet Rec Open. 2(1):e000063. PMID: 26392889; PMCID: PMC4567176.
  • Kriston-Pál É, Czibula Á, Gyuris Z, Balka G, Seregi A, Sükösd F, Süth M, Kiss-Tóth E, Haracska L, Uher F, et al. 2017. Characterization and therapeutic application of canine adipose mesenchymal stem cells to treat elbow osteoarthritis. Can J Vet Res. 81(1):73–78. PMID: 28197017; PMCID: PMC5220603.
  • Lai RC, Yeo RW, Tan KH, Lim SK. 2013. Mesenchymal stem cell exosome ameliorates reperfusion injury through proteomic complementation. Regen Med. 8(2):197–209. PMID: 23477399.
  • Li JJ, Hosseini-Beheshti E, Grau GE, Zreiqat H, Little CB. 2019. Stem cell-derived extracellular vesicles for treating joint injury and osteoarthritis. Nanomaterials (Basel). 9(2):261. PMID: 30769853; PMCID: PMC6409698.
  • Loeser RF, Goldring SR, Scanzello CR, Goldring MB. 2012. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 64(6):1697–1707. Epub 2012 Mar 5. PMID: 22392533; PMCID: PMC3366018.
  • Mocchi M, Bari E, Dotti S, Villa R, Berni P, Conti V, Del Bue M, Squassino GP, Segale L, Ramoni R, et al. 2021. Canine mesenchymal cell lyosecretome production and safety evaluation after allogenic intraarticular injection in osteoarthritic dogs. Animals (Basel). 11(11):3271. PMID: 34828003; PMCID: PMC8614457.
  • Olsen A, Johnson V, Webb T, Santangelo KS, Dow S, Duerr FM. 2019. Evaluation of intravenously delivered allogeneic mesenchymal stem cells for treatment of elbow osteoarthritis in dogs: a pilot study. Vet Comp Orthop Traumatol. 32(3):173–181. Epub 2019 Mar 14. PMID: 30873568.
  • Peláez P, Damiá E, Torres-Torrillas M, Chicharro D, Cuervo B, Miguel L, Del Romero A, Carrillo JM, Sopena JJ, Rubio M. 2021. Cell and cell free therapies in osteoarthritis. Biomedicines. 9(11):1726. PMID: 34829953; PMCID: PMC8615373.
  • Pye C, Bruniges N, Peffers M, Comerford E. 2022. Advances in the pharmaceutical treatment options for canine osteoarthritis. J Small Anim Pract. 63(10):721–738. PMID: 35285032.
  • Sabry D, Shamaa A, Amer M, El-Tookhy O, Abdallah A, Abd El Hassib DM, Amer E, Elamir A. 2018. The effect of mesenchymal stem cell derived microvesicles in repair of femoral chondral defects in dogs. J Musculoskelet Res. 21(2):1850006.
  • Sasaki A, Mizuno M, Mochizuki M, Sekiya I. 2019. Mesenchymal stem cells for cartilage regeneration in dogs. World J Stem Cells. 11(5):254–269. PMID: 31171954; PMCID: PMC6545524.
  • Sasaki A, Mizuno M, Ozeki N, Katano H, Otabe K, Tsuji K, Koga H, Mochizuki M, Sekiya I. 2018. Canine mesenchymal stem cells from synovium have a higher chondrogenic potential than those from infrapatellar fat pad, adipose tissue, and bone marrow. PLoS One. 13(8):e0202922. PMID: 30138399; PMCID: PMC6107231.
  • Satué M, Schüler C, Ginner N, Erben RG. 2019. Intra-articularly injected mesenchymal stem cells promote cartilage regeneration, but do not permanently engraft in distant organs. Sci Rep. 9(1):10153. PMID: 31300685; PMCID: PMC6626061.
  • Sharun K, Dhama K, Jambagi K, Pawde, AM, Amarpal. 2022. Cell-free therapy for inflammatory diseases: opportunities and challenges. Recent Adv Inflamm Allergy Drug Discov. 15(1):5–8. PMID: 34931977.
  • Sze SK, de Kleijn DP, Lai RC, Khia Way Tan E, Zhao H, Yeo KS, Low TY, Lian Q, Lee CN, Mitchell W, et al. 2007. Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells. Mol Cell Proteomics. 6(10):1680–1689. Epub 2007 Jun 11. PMID: 17565974.
  • Tao SC, Yuan T, Zhang YL, Yin WJ, Guo SC, Zhang CQ. 2017. Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model. Theranostics. 7(1):180–195. PMID: 28042326; PMCID: PMC5196895.
  • Tofiño-Vian M, Guillén MI, Alcaraz MJ. 2018. Extracellular vesicles: a new therapeutic strategy for joint conditions. Biochem Pharmacol. 153:134–146. Epub 2018 Feb 7. PMID: 29427625.
  • Whitworth DJ, Banks TA. 2014. Stem cell therapies for treating osteoarthritis: prescient or premature? Vet J. 202(3):416–424. Epub 2014 Sep 30. PMID: 25457267.
  • Wright A, Amodie DM, Cernicchiaro N, Lascelles BDX, Pavlock AM, Roberts C, Bartram DJ. 2022. Identification of canine osteoarthritis using an owner-reported questionnaire and treatment monitoring using functional mobility tests. J Small Anim Pract. 63(8):609–618. PMID: 35385129. PMCID: PMC9543207.
  • Zeng Z, Dai Y, Deng S, Zou S, Dou T, Wei F. 2022. Synovial mesenchymal stem cell-derived extracellular vesicles alleviate chondrocyte damage during osteoarthritis through microRNA-130b-3p-mediated inhibition of the LRP12/AKT/β-catenin axis. Immunopharmacol Immunotoxicol. 44(2):247–260. Epub 2022 Feb 17. PMID: 35174753.
  • Zhao C, Chen JY, Peng WM, Yuan B, Bi Q, Xu YJ. 2020. Exosomes from adipose-derived stem cells promote chondrogenesis and suppress inflammation by upregulating miR-145 and miR-221. Mol Med Rep. 21(4):1881–1889. Epub 2020 Feb 7. PMID: 32319611; PMCID: PMC7057766.